NONLINEAR PHARMACOKINETIC CHARACTERISTICS OF 5-FLUOROURACIL (5-FU) IN COLORECTAL-CANCER PATIENTS

被引：50

作者：

SCHAAF, LJ

DOBBS, BR

EDWARDS, IR

PERRIER, DG

机构：

[1] UNIV OTAGO,SCH MED,DEPT PHARM,DUNEDIN,NEW ZEALAND

[2] UNIV OTAGO,SCH MED,MRC NEW ZEALAND,TOXICOL RES UNIT,DUNEDIN,NEW ZEALAND

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 32卷 / 04期

关键词：

D O I：

10.1007/BF00543978

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：411 / 418

页数：8

共 24 条

[1]

AUBERT C, 1981, B CANCER, V68, P343

[2] QUANTITATIVE-ANALYSIS OF 5-FLUOROURACIL AND 5,6-DIHYDROFLUOROURACIL IN PLASMA BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].

AUBERT, C ;

SOMMADOSSI, JP ;

COASSOLO, P ;

CANO, JP ;

RIGAULT, JP .

BIOMEDICAL MASS SPECTROMETRY, 1982, 9 (08) :336-339

[3] NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].

BENET, LZ ;

GALEAZZI, RL .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074

[4]

BENET LZ, 1984, PHARMACOKINETIC BASI

[5] HEPATIC CIRCULATION IN CIRRHOSIS OF THE LIVER [J].

BRADLEY, SE ;

INGELFINGER, FJ ;

BRADLEY, GP .

CIRCULATION, 1952, 5 (03) :419-429

[6] ENHANCED 5-FLUOROURACIL NUCLEOTIDE FORMATION AFTER METHOTREXATE ADMINISTRATION - EXPLANATION FOR DRUG SYNERGISM [J].

CADMAN, E ;

HEIMER, R ;

DAVIS, L .

SCIENCE, 1979, 205 (4411) :1135-1137

[7] DOXORUBICIN AND 5-FLUOROURACIL PLASMA-CONCENTRATIONS AND DETECTABILITY IN PAROTID-SALIVA [J].

CELIO, LA ;

DIGREGORIO, GJ ;

RUCH, E ;

PACE, J ;

PIRAINO, AJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (02) :261-266

[8] NON-LINEAR PHARMACOKINETIC MODELS FOR 5-FLUOROURACIL IN MAN - INTRAVENOUS AND INTRAPERITONEAL ROUTES [J].

COLLINS, JM ;

DEDRICK, RL ;

KING, FG ;

SPEYER, JL ;

MYERS, CE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :235-246

[9]

Diem K., 1970, SCI TABLES, V6

[10]

FINCH RE, 1979, BRIT J CLIN PHARMACO, V7, P613, DOI 10.1111/j.1365-2125.1979.tb04651.x

← 1 2 3 →